AVDL - Avadel Pharmace Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (0.64%) XEL (0.43%) VUZI (2.34%) SSYS (11.12%) SQQQ (-1.84%) SQ (5.78%) SEDG (-2.17%) RNG (-3.77%) QIWI (-1.61%) PCAR (-1.25%)

AVDL - Avadel Pharmaceutica...

$7.58 -0.23[-2.95%]

15 mins delayed data

People also watch : EGRX | DRRX | HRTX | ALKS | TEVA | NKTR

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$7.81	Open	$7.82
Volume	366K	Market Cap	456.79M
Yield		Last Dividend

Day

52 Week

Avadel Pharmaceuticals, The Jazz-Killer	6:33 AM
No summary available.

Avadel Pharmaceuticals to Provide a Corp...	08/02/21
DUBLIN, Ireland, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company primarily focused on developing FT218, an inve...

Avadel Pharmaceuticals to Present at the...	07/07/21
DUBLIN, Ireland, July 07, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigationa...

Avadel Pharmaceuticals (NASDAQ-AVDL) Sha...	06/30/21
Avadel Pharmaceuticals (NASDAQ:AVDL) Share Prices Have Dropped 34% In The Last Five Years Yahoo Finance

Rabeprazole to Register Substantial Expa...	06/13/21
The global Rabeprazole market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strate...

Avadel presents new clinical data from P...	06/09/21
No summary available.

Avadel Presents New Clinical Data from P...	06/09/21
DUBLIN, Ireland, June 09, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigationa...

DEFR14A: DEFR14A	06/04/21
AVADEL PHARMACEUTICALS PLC

Avadel Pharmaceuticals (AVDL) Investor P...	06/02/21
No summary available.

Avadel to Present New Efficacy and Safet...	06/02/21
Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for t...

Avadel Pharmaceuticals Expands Leadershi...	06/01/21
Bolsters team with addition of established biopharma industry leaders in advance of anticipated regulatory approval and commercialization of once-nigh...

Avadel Pharmaceuticals to Present at the...	05/25/21
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational...

Avadel Pharmaceuticals to Present at the...	05/24/21
Avadel Pharmaceuticals plc, a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessi...

Psychedelic Drugs Market 2021: Future Pr...	05/19/21
The Psychedelic drugs market demand, Industry Growth is anticipated to flourish indepth overview during the forecast period 2021-2027. The report offe...

H.C. Wainwright Keeps a Buy Rating on Av...	05/17/21
In a report released today, Oren Livnat from H.C. The post H.C. Wainwright Keeps a Buy Rating on Avadel Pharmaceuticals (AVDL) appeared first on Smart...

Avadel reports steep losses after sale o...	05/15/21
Avadel Pharmaceuticals reported a net loss of $13.4 million, which the company attributed to the sale of a sterile, injectable drug portfolio.

Analysts Offer Insights on Healthcare Co...	05/13/21
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amicus (FOLD), AVEO Pharma (AVEO) and The post Analy...

Analysts Top Healthcare Picks: Avadel Ph...	05/11/21
Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avadel Pharmaceuticals (AVDL), Geron (GERN) The post An...

ANALYST RATINGS

1 analyst ratings (Last 3 months)

100.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $AVDL

Service Name	Trader	% Success
TopFlight Trades - Short Plays	Eric Cunningham	40.00 %	Follow
Biotechnology	Robert Gadimian	26.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.